Community SDoH Alert!

COMPANY ANNOUNCEMENT – Diabetes drug Metformin recalled due to high levels of cancer-causing agent.

  • Alert date October 11, 2020

    VISIT WEBSITE

    Contact: Diabetes drug Metformin recalled due to high levels of cancer-causing agent.

    Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
    Summary
    Company Announcement Date:
    October 02, 2020
    FDA Publish Date:
    October 05, 2020
    Product Type:
    Drugs
    Reason for Announcement:
    Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
    Company Name:
    Marksans Pharma Limited
    Brand Name:
    Time-Cap Labs Inc.
    Product Description:
    Metformin Hydrochloride for Extended-Release Tablets, USP 500 mg and 700 mg

    Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant found in water and foods, including meats, dairy products and vegetables. Marksans Pharma Limited has not received any reports of adverse events that have been related to this recall.

Use the share buttons below to share alert with your community
If you are on a phone use the GREEN SMS button to directly send a text

show translator

AmharicEnglishSomali

COPYRIGHT © 2019 SISTERS IN COMMON